Joe Rogan — The Supplement-Industrial Complex

Joe Rogan's $250 million Spotify deal fuels a supplement pipeline where guest mentions spike sales 500% for products like Onnit's Alpha Brain nootropics and adaptogens. His biohacking empire, including testosterone replacement therapy and cold plunges, targets a demographic that sees Gwyneth Paltrow as too soft - yet it outperforms #5 Alex Jones's InfoWars in mainstream reach by 40% due to Rogan's massive audience. Unlike Kate Hudson's Fabletics (#7), which focuses on apparel subscriptions, Rogan's success is purely influence-driven: he doesn't sell wellness as aspiration but as performance enhancement, proving that supplements thrive on audience size, not ethics. The $165 million InfoWars haul shows this model's dark side, but Rogan's Unilever acquisition of Onnit legitimizes it.